KR20130135819A - 피부 항노화 처리 - Google Patents

피부 항노화 처리 Download PDF

Info

Publication number
KR20130135819A
KR20130135819A KR1020137000438A KR20137000438A KR20130135819A KR 20130135819 A KR20130135819 A KR 20130135819A KR 1020137000438 A KR1020137000438 A KR 1020137000438A KR 20137000438 A KR20137000438 A KR 20137000438A KR 20130135819 A KR20130135819 A KR 20130135819A
Authority
KR
South Korea
Prior art keywords
substituted
unsubstituted
group
seq
stimulants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020137000438A
Other languages
English (en)
Korean (ko)
Inventor
유한 세브리안 푸체
누리아 알미나나 도메네크
라? 델가도 곤잘레스
Original Assignee
리포텍 에스.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 리포텍 에스.에이. filed Critical 리포텍 에스.에이.
Publication of KR20130135819A publication Critical patent/KR20130135819A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020137000438A 2010-06-09 2011-06-08 피부 항노화 처리 Ceased KR20130135819A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/797,222 2010-06-09
US12/797,222 US20110305735A1 (en) 2010-06-09 2010-06-09 Skin antiaging treatment
PCT/EP2011/002799 WO2011154126A2 (en) 2010-06-09 2011-06-08 Skin antiaging treatment

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020187020082A Division KR20180083958A (ko) 2010-06-09 2011-06-08 피부 항노화 처리

Publications (1)

Publication Number Publication Date
KR20130135819A true KR20130135819A (ko) 2013-12-11

Family

ID=44627143

Family Applications (4)

Application Number Title Priority Date Filing Date
KR1020137000438A Ceased KR20130135819A (ko) 2010-06-09 2011-06-08 피부 항노화 처리
KR1020217021742A Ceased KR20210090731A (ko) 2010-06-09 2011-06-08 피부 항노화 처리
KR1020197035199A Ceased KR20190135555A (ko) 2010-06-09 2011-06-08 피부 항노화 처리
KR1020187020082A Ceased KR20180083958A (ko) 2010-06-09 2011-06-08 피부 항노화 처리

Family Applications After (3)

Application Number Title Priority Date Filing Date
KR1020217021742A Ceased KR20210090731A (ko) 2010-06-09 2011-06-08 피부 항노화 처리
KR1020197035199A Ceased KR20190135555A (ko) 2010-06-09 2011-06-08 피부 항노화 처리
KR1020187020082A Ceased KR20180083958A (ko) 2010-06-09 2011-06-08 피부 항노화 처리

Country Status (13)

Country Link
US (1) US20110305735A1 (enExample)
EP (1) EP2579952B1 (enExample)
JP (2) JP6306885B2 (enExample)
KR (4) KR20130135819A (enExample)
CN (1) CN103096980B (enExample)
AU (1) AU2011264125B2 (enExample)
BR (1) BR112012031117B1 (enExample)
CA (1) CA2801961C (enExample)
CO (1) CO6640331A2 (enExample)
ES (1) ES2654342T3 (enExample)
MX (1) MX342853B (enExample)
WO (1) WO2011154126A2 (enExample)
ZA (1) ZA201209484B (enExample)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016167545A1 (ko) * 2015-04-13 2016-10-20 주식회사 엘지생활건강 신경전달물질의 배출을 조절하는 성분이 포함된 용해성 마이크로니들
KR20160122625A (ko) * 2015-04-14 2016-10-24 주식회사 엘지생활건강 칼슘채널 차단제 전달용 용해성 미세바늘
KR20180005919A (ko) * 2016-07-07 2018-01-17 주식회사 한국화장품제조 펩타이드 리포좀을 포함하는 스틱형 화장료 조성물
US10391289B2 (en) 2015-04-13 2019-08-27 Lg Household & Health Care Ltd. Soluble microneedle containing ingredient for controlling release of neurotransmitters
KR20190101686A (ko) * 2018-02-23 2019-09-02 주식회사 메디쿼터스 미세먼지 차단용 피부화장료 조성물 및 겔 조성물
KR20200049122A (ko) * 2018-10-31 2020-05-08 에이앤펩주식회사 기능성 펩타이드와 발효물을 포함하는 피부노화 개선용 조성물

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9486408B2 (en) * 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
US9125907B2 (en) * 2009-09-30 2015-09-08 Christopher Shaari Use of botulinum neurotoxin to treat substance addictions
RU2613121C2 (ru) 2011-05-10 2017-03-15 Мэри Кэй Инк. Косметические композиции
JP5889220B2 (ja) * 2012-03-30 2016-03-22 富士フイルム株式会社 水性分散組成物
EP2649984A1 (en) * 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis
US8758783B1 (en) 2012-12-20 2014-06-24 L'oreal Water-in-oil emulsion comprising pigments in the water phase
RU2524663C1 (ru) * 2013-04-26 2014-07-27 Общество с ограниченной ответственностью "ДЖИ-Групп" Комплексное косметическое средство
CN103505377B (zh) * 2013-09-11 2015-06-03 深圳市维琪医药研发有限公司 一种具皮肤活性的多肽组合物
EP3062889A2 (en) 2013-11-01 2016-09-07 Spherium Biomed S.L. Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
CN103637925B (zh) * 2013-12-03 2015-09-30 广州健坤生物科技有限公司 γ-氨基丁酸(GABA)和一种小肽在化妆品中的联合应用
CN103641888B (zh) * 2013-12-03 2015-08-12 广州健坤生物科技有限公司 一种多功能新型小肽、包含该肽的组合物及其应用
CN104000744A (zh) * 2014-06-12 2014-08-27 金玲 一种改善肌肤新陈代谢并能延缓衰老的美容用液及其生产方法
EP3188706B1 (en) 2014-09-02 2019-10-09 American Silver, LLC Botulinum toxin and colloidal silver particles
KR101843065B1 (ko) * 2016-01-06 2018-03-28 바이오스펙트럼 주식회사 카노신, 대두 펩타이드 및 천심련 추출물을 포함하는 항노화용 조성물
US10493020B2 (en) 2016-04-14 2019-12-03 The Procter & Gamble Company Method of improving the appearance of periorbital dyschromia
US11478409B2 (en) * 2016-05-24 2022-10-25 Natura Cosmeticos S.A. Anti-wrinkle cosmetic composition, composition system and method for cosmetic skin treatment
US20180133131A1 (en) * 2016-11-14 2018-05-17 Ariix Skin rejuvenating compositions
BR112019010131A2 (pt) 2016-11-21 2019-10-08 Eirion Therapeutics Inc entrega transdérmica de agentes grandes
WO2018154080A1 (en) * 2017-02-24 2018-08-30 Lipotrue, S.L. Peptides and compositions for use in cosmetics
US10258556B2 (en) * 2017-06-19 2019-04-16 Yu-Chun Liu Anti-aging peptide, its composition and method of using the same
KR102311724B1 (ko) * 2017-09-15 2021-10-13 (주)아모레퍼시픽 슈도알터로모나스 펩티도라이티카의 배양물 또는 이의 추출물을 포함하는 피부 미백용 조성물
CN107693391A (zh) * 2017-11-21 2018-02-16 上海合轩品牌管理有限公司 一种抗皱眼霜及其制备方法
EP3843777A4 (en) * 2018-08-28 2022-05-04 Ira Sanders THERAPEUTICS FOR THE SKIN
CN109293737B (zh) * 2018-09-27 2020-10-27 华南理工大学 一种抗皮肤衰老的四肽及其用途
CN118324862A (zh) * 2018-12-26 2024-07-12 思亲美有限公司 乙酰胆碱受体抑制肽及其用途
GB202004804D0 (en) * 2020-04-01 2020-05-13 Neuro Bio Ltd Skin
CN111904881B (zh) * 2020-08-11 2023-05-23 上海科颜生物科技有限公司 一种抗衰紧致组合物及其制备方法和应用
CN113307851B (zh) * 2021-06-11 2022-04-29 珠海医美企业管理有限公司 一种改善皮肤生理特性的活性肽与间充质干细胞外泌体在药品或化妆品中的应用
CN113577364A (zh) * 2021-08-13 2021-11-02 常州谙美生物科技有限公司 一种用于晒后修复的医用敷料
CN115400043B (zh) * 2022-08-04 2023-10-31 广州环亚化妆品科技股份有限公司 一种抗皱组合物及其制备方法和在化妆品中的应用
CN116003518B (zh) * 2023-01-10 2023-09-29 深圳市维琪科技股份有限公司 经设计的肽及其组合物和用途
CN116747148B (zh) * 2023-07-24 2024-10-01 山东福瑞达生物股份有限公司 一种适用于敏感肌的抗衰化妆品组合物
KR102834921B1 (ko) * 2023-08-14 2025-07-18 허가영 조직수복 및 피부탄력 개선용 조성물
CN117297997B (zh) * 2023-11-28 2024-03-19 杭州湃肽生化科技有限公司 一种高效紧肤多肽组合物及其产品应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69529043T2 (de) 1994-09-30 2003-05-08 L'oreal S.A., Paris Verwendung von einem Agonisten eines mit einem Chloridkanal assozierten Rezeptors zur Behandlung von Hautfalten
AU2334897A (en) * 1996-03-18 1997-10-10 Regents Of The University Of California, The Peptide inhibitors of neurotransmitter secretion by neuronal cells
FR2746641B1 (fr) 1996-03-27 1998-06-05 Oreal Utilisation d'un extrait d'au moins une iridacee dans le traitement des rides
ES2160485B1 (es) * 1999-04-23 2002-05-16 Lipotec Sa Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen.
FR2798590B1 (fr) 1999-09-21 2001-11-30 Oreal Utilisation de l'alverine pour diminuer les rides
US7780967B2 (en) * 2000-02-08 2010-08-24 Allergan, Inc. Reduced toxicity Clostridial toxin pharmaceutical compositions
FR2809005B1 (fr) 2000-05-18 2002-12-27 Oreal Utilisation du manganese dans le traitement des rides
FR2846885B1 (fr) 2002-11-13 2004-12-24 Oreal Utilisation d'une association de composants a effet synergique inhibiteur de canaux calciques pour prevenir ou traiter les ridules
ES2259928B1 (es) * 2005-04-08 2007-11-01 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica que comprende peptidos derivados de encefalinas para reducir y/o eliminar arrugas faciales.
ES2322882B1 (es) * 2006-10-25 2010-04-22 Lipotec Sa Peptidos inhibidores de la exocitosis neuronal.

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016167545A1 (ko) * 2015-04-13 2016-10-20 주식회사 엘지생활건강 신경전달물질의 배출을 조절하는 성분이 포함된 용해성 마이크로니들
US10391289B2 (en) 2015-04-13 2019-08-27 Lg Household & Health Care Ltd. Soluble microneedle containing ingredient for controlling release of neurotransmitters
US11577063B2 (en) 2015-04-13 2023-02-14 Lg Household & Health Care Ltd. Soluble microneedle containing ingredient for controlling release of neurotransmitters
KR20160122625A (ko) * 2015-04-14 2016-10-24 주식회사 엘지생활건강 칼슘채널 차단제 전달용 용해성 미세바늘
KR20180005919A (ko) * 2016-07-07 2018-01-17 주식회사 한국화장품제조 펩타이드 리포좀을 포함하는 스틱형 화장료 조성물
KR20190101686A (ko) * 2018-02-23 2019-09-02 주식회사 메디쿼터스 미세먼지 차단용 피부화장료 조성물 및 겔 조성물
KR20200049122A (ko) * 2018-10-31 2020-05-08 에이앤펩주식회사 기능성 펩타이드와 발효물을 포함하는 피부노화 개선용 조성물

Also Published As

Publication number Publication date
AU2011264125A1 (en) 2012-12-20
BR112012031117B1 (pt) 2018-01-16
EP2579952B1 (en) 2017-11-08
JP2018058842A (ja) 2018-04-12
WO2011154126A2 (en) 2011-12-15
CA2801961C (en) 2018-11-20
CO6640331A2 (es) 2013-03-22
MX342853B (es) 2016-10-14
JP2013533226A (ja) 2013-08-22
CA2801961A1 (en) 2011-12-15
JP6306885B2 (ja) 2018-04-04
WO2011154126A3 (en) 2012-07-26
CN103096980B (zh) 2018-02-09
KR20190135555A (ko) 2019-12-06
ES2654342T3 (es) 2018-02-13
AU2011264125B2 (en) 2015-03-19
BR112012031117A2 (pt) 2016-08-23
EP2579952A2 (en) 2013-04-17
ZA201209484B (en) 2014-02-26
MX2012014389A (es) 2013-01-29
KR20180083958A (ko) 2018-07-23
KR20210090731A (ko) 2021-07-20
US20110305735A1 (en) 2011-12-15
CN103096980A (zh) 2013-05-08

Similar Documents

Publication Publication Date Title
CA2801961C (en) Skin antiaging treatment
CN104968360B (zh) 用于治疗和/或护理皮肤、毛发和/或粘膜的化合物以及它们的化妆美容或药物组合物
KR101757946B1 (ko) 근 수축을 억제하는 화합물
JP5818356B2 (ja) 皮膚、粘膜、頭皮、及び／若しくは毛髪の処置及び／若しくはケアに有用なペプチド並びに／又は化粧品組成物若しくは医薬組成物におけるその使用
JP2022019764A (ja) ペプチド化合物、それらを含む組成物及び前記化合物の使用、特に化粧用途
JP7686563B2 (ja) 皮膚、毛髪、爪および／または粘膜の処置および／またはケアに有用な化合物
JP6470679B2 (ja) ニューロンの開口分泌を阻害する化合物（ｉｉｉ）
KR20120105450A (ko) 피부, 점막 및/또는 모발의 치료 및/또는 관리에 사용되는 펩티드 및 화장품학적 또는 약제학적 조성물에 있어서의 이의 용도
JP2014510091A (ja) ＰＧＣ−１αを調節するペプチド
US20130078295A1 (en) Skin antiaging treatment
JP7526159B2 (ja) 皮膚、毛髪、爪および／または粘膜の処置および／またはケアに有用な化合物
JP2025527593A (ja) 皮膚、毛髪、爪及び／又は粘膜の処置及び／又はケアに有用な化合物

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20130107

Patent event code: PA01051R01D

Comment text: International Patent Application

AMND Amendment
PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20160527

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20170720

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20180130

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20170720

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20180130

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20170919

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20130110

Comment text: Amendment to Specification, etc.

PX0601 Decision of rejection after re-examination

Comment text: Decision to Refuse Application

Patent event code: PX06014S01D

Patent event date: 20180604

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20180502

Comment text: Decision to Refuse Application

Patent event code: PX06011S01I

Patent event date: 20180130

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20170919

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20170720

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20130110

PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20180713